Patent details

EP2788316 Title: BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS

  • Data
  • Documents

Basic Information

Publication number:
EP2788316
PCT Application Number:
US2012068450
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128158789
PCT Publication Number:
WO2013086322
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BRANCHED ALKYL AND CYCLOALKYL TERMINATED BIODEGRADABLE LIPIDS FOR THE DELIVERY OF ACTIVE AGENTS
French Title of Invention:
LIPIDES BIODÉGRADABLES RAMIFIÉS À TERMINAISONS ALKYLE ET CYCLOALKYLE DESTINÉS À L'ADMINISTRATION D'AGENTS ACTIFS
German Title of Invention:
VERZWEIGTE ALKYL- UND CYCLOALKYL-TERMINIERTE BIOLOGISCH ABBAUBARE LIPIDE ZUR VERABREICHUNG VON WIRKSTOFFEN
SPC Number:

Dates

Filing date:
07/12/2012
Grant date:
24/04/2019
EP Publication Date:
15/10/2014
PCT Publication Date:
13/06/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/04/2019
EP B1 Publication Date:
24/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/12/2019
Expiration date:
07/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/04/2019
 
 

Name:
Alnylam Pharmaceuticals, Inc.
Address:
300 Third Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
DU, Xinyao
Address:
United States (US)

2

Name:
ANSELL, Steven, Michial
Address:
Canada (CA)

Priority

Priority Number:
201161568121 P
Priority Date:
07/12/2011
Priority Country:
United States (US)

Classification

IPC classification:
C07C 217/08; C07C 229/12;

Publication

European Patent Bulletin

Issue number:
201917
Publication date:
24/04/2019
Description:
Grant (B1)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: